Streetwise Tools & Diagnostics Articles
Telehealth Tech Company Continues Rapid Growth in COVID-Changed Landscape
Source: Streetwise Reports (2/24/21)
Reliq Health introduces iUGO Home services and just added a care management network in California with 50 clinics and over 500 physicians.
More >
Analyst: All Systems Are Go for Testing, Testing and More Testing
Source: Streetwise Reports (2/24/21)
This Dawson James report explains why ProPhase Labs is perfectly positioned to benefit from expanded COVID testing.
More >
Pacific Biosciences Shares Rise 22% on $900 Million Investment from Japan's SoftBank
Source: Streetwise Reports (2/10/21)
Shares of Pacific Biosciences of California traded to a new 52-week high after the firm reported that a Softbank Group subsidiary will invest $900 million to support its growth initiatives.
More >
Align Technology Shares Grind 12.5% Higher after Firm Posts Record Q4 Revenue of $834.5 Million
Source: Streetwise Reports (2/4/21)
Align Technology shares set a new 52-week high after the company announced financial results that included record FY/20 total revenues of $2.5 billion.
More >
Abiomed Shares Gain 8% After Firm Announces Record Q3 Revenue of $232 Million
Source: Streetwise Reports (1/28/21)
Shares of cardiac medical device maker Abiomed Inc. traded higher after the company reported record revenue for Q3/21 despite the impact from COVID-19.
More >
A Solace to the Stress of the SolarWinds Hack
Source: Jack Hurley for Streetwise Reports (1/21/21)
Against the backdrop of the massive SolarWinds hack, value investor Jack Hurley discusses his investment thesis for Leonovus Inc., whose products provide an "ironclad level of cybersecurity."
More >
Imagin Medical Is Bringing Cystoscopy into the 21st Century
Source: Dr. KSS, MD, PhD, for Streetwise Reports (1/21/21)
Dr. KSS, MD, PhD, editor-in-chief of PubBio.co, profiles a small cap that "is poised to bring to clinic a next-generation of must-have cystoscopy equipment."
More >
Neurosciences Firm Outlines Strategic Priorities for 2021
Source: Streetwise Reports (1/15/21)
ProMIS Neurosciences discusses its four priority areas in 2021.
More >
Avinger Shares Rise 40% on Launch of Image-Guided Device to Diagnose and Treat PAD
Source: Streetwise Reports (1/15/21)
Shares of Avinger Inc. reached a new 52-week high after the company reported it initiated a full commercial launch of its Tigereyeâ„¢ Image-Guided CTO Crossing Catheter system for diagnosing and treating peripheral artery disease.
More >
This Tiny Digital Healthcare Company's Sales Should Rocket Higher
Source: Matt Badiali for Streetwise Reports (1/6/21)
Independent financial analyst Matt Badiali profiles a small cap whose blood glucose monitoring system works with any smartphone.
More >
This Tiny Tech Stock Is Quietly Building a Huge Business in Air Quality
Source: Matt Badiali for Streetwise Reports (1/5/21)
Independent financial analyst Matt Badiali discusses how mCloud's technology is making it possible for office buildings to reopen during the pandemic.
More >
California Biotech Advances Two COVID-19 Products
Source: Streetwise Reports (12/30/20)
Recent news concerning Sorrento Therapeutics' SARS-CoV-2 virus test and antibodies is discussed in a Dawson James Securities report.
More >
DermTech Shares Rise 32% on Geisinger Health Support for Skin Cancer Test
Source: Streetwise Reports (12/30/20)
Shares of DermTech Inc. climbed to a new 52-week high after the company reported it has received positive medical coverage by Geisinger Health System for its pigmented lesion assay, a non-invasive test for detecting melanoma.
More >
BioTelemetry Shares Beat Higher on Royal Philips $2.8 Billion Buyout Offer
Source: Streetwise Reports (12/18/20)
Shares of BioTelemetry Inc. rise 16.5% to a new 52-week high after Royal Philips agreed to acquire the company for US$2.8 billion, or US$72.00 per share in an all cash transaction.
More >
Biotech's Potentially Disruptive Diagnostics Platform on 'Cusp of Commercialization'
Source: Streetwise Reports (12/6/20)
Recent trial results, a timeline to the launch of Quotient's system and the reasons the debut should be successful are discussed in a Cowen report.
More >
Renalytix AI Shares Climb 30% on Q1 Earnings and EUA for JV's SARS-CoV-2 IgG Antibody Test Kit
Source: Streetwise Reports (11/25/20)
Shares of Renalytix AI Plc. traded 30% higher after the company reported Q1/21 financial results and that its joint venture with Mt. Sinai Health System was granted Emergency Use Authorization by the FDA for its SARS-CoV-2 IgG antibody test kit.
More >
Biotech Involved in COVID-19, Neurodegenerative Diseases Reports Q3/20 Results
Source: Streetwise Reports (11/12/20)
ProMIS Neurosciences formed two new joint ventures, one for developing tests for the detection, diagnosis and monitoring of Alzheimer's disease, and the second for serological assays for antibodies to the SARS-CoV-2 virus.
More >
Individuals Succeed Using This Digital Therapy—Now It's Moving to Insurers
Source: Matt Badiali for Streetwise Reports (11/10/20)
Independent financial analyst Matt Badiali profiles a digital therapeutics company that is changing diabetes treatment.
More >
Inspire Medical's Shareholders Rest Comfortably on Q3 Earnings and Raised FY Outlook
Source: Streetwise Reports (11/3/20)
Shares of Inspire Medical Systems traded 30% higher and set a new 52-week high after the company reported Q3/20 financial results that included a 72% rise in YoY revenue.
More >
Exact Sciences Shares Rise 29% as Firm Announces Q3 Earnings, a Capital Raise and Two Acquisitions
Source: Streetwise Reports (10/27/20)
Exact Sciences Corp. shares reached a new 52-week high after the maker of cancer screening test Cologuard reported Q3/20 financial results that included a greater than 86% increase in year-over-year revenue.
More >
CareDx Shares Trade Up 15% After Announcing 57% YoY Increase in Q3 Revenue
Source: Streetwise Reports (10/8/20)
CareDx shares established a new 52-week high after the company reported that preliminary revenue in Q3/20 increased 57% year-over-year to $53.0 million.
More >
American Renal Associates Agrees to Private Equity Firm's $853 Million Buyout Offer
Source: Streetwise Reports (10/2/20)
Shares of American Renal Associates traded 67% higher and set a new 52-week high after the company reported that it has entered into a definitive agreement to be acquired by a Nautic Partners LLC affiliate for $11.50 per share in cash.
More >
Genetron Receives FDA Breakthrough Approval for Hepatocellular Carcinoma Detection Device
Source: Streetwise Reports (9/30/20)
Genetron Holdings Ltd. shares traded 25% higher after the company reported it has received Breakthrough Device Designation from the FDA for its blood-based next-generation sequencing test for early hepatocellular carcinoma detection.
More >
Aptorum Shares Skyrocket Upon Launching Infectious Disease Liquid Biopsy Unit
Source: Streetwise Reports (9/29/20)
Shares of Aptorum Group Ltd. traded nearly 300% higher after the company reported it launched an infectious disease liquid biopsy start-up subsidiary.
More >
Bringing Order to Information Chaos Is a Necessity in the Age of COVID-19
Source: Streetwise Reports (8/31/20)
Leonovus, a data storage and security technology firm, positions its software to enable healthcare groups to organize massive amounts of COVID/public health data.
More >


